Abstract
Bacterial biofilms on medical devices are a primary source of infection, and efforts have been made to develop means of decontaminating colonized devices including hemodialysis catheter “lock” solutions. Because bacterial biofilms are inherently resistant to many antibiotics and widespread use of antibiotics contributes to resistance development, there is a need for new approaches to biofilm eradication. We have developed a class of compounds, termed ceragenins, that mimic the antimicrobial activities of antimicrobial peptides. The ceragenins are active against established biofilms. We tested solutions of a lead ceragenin, CSA-13, with and without EGTA against biofilms comprised of Gram-negative and positive organisms. Similar solutions containing ciprofloxacin were used as comparators. The ceragenin solutions eradicated biofilms at concentrations comparable to those required for eradication by ciprofloxacin. However, against a methicillin- resistant strain of Staphylococcus aureus, CSA-13 proved to be far superior to ciprofloxacin.
Anti-Infective Agents in Medicinal Chemistry
Title: Activities of Ceragenin CSA-13 Against Established Biofilms in an In Vitro Model of Catheter Decolonization
Volume: 8 Issue: 4
Author(s): Jacob Pollard, Jon Wright, Yanshu Feng, Dianliang Geng, Carl Genberg and Paul B. Savage
Affiliation:
Abstract: Bacterial biofilms on medical devices are a primary source of infection, and efforts have been made to develop means of decontaminating colonized devices including hemodialysis catheter “lock” solutions. Because bacterial biofilms are inherently resistant to many antibiotics and widespread use of antibiotics contributes to resistance development, there is a need for new approaches to biofilm eradication. We have developed a class of compounds, termed ceragenins, that mimic the antimicrobial activities of antimicrobial peptides. The ceragenins are active against established biofilms. We tested solutions of a lead ceragenin, CSA-13, with and without EGTA against biofilms comprised of Gram-negative and positive organisms. Similar solutions containing ciprofloxacin were used as comparators. The ceragenin solutions eradicated biofilms at concentrations comparable to those required for eradication by ciprofloxacin. However, against a methicillin- resistant strain of Staphylococcus aureus, CSA-13 proved to be far superior to ciprofloxacin.
Export Options
About this article
Cite this article as:
Pollard Jacob, Wright Jon, Feng Yanshu, Geng Dianliang, Genberg Carl and Savage B. Paul, Activities of Ceragenin CSA-13 Against Established Biofilms in an In Vitro Model of Catheter Decolonization, Anti-Infective Agents in Medicinal Chemistry 2009; 8 (4) . https://dx.doi.org/10.2174/187152109789760225
DOI https://dx.doi.org/10.2174/187152109789760225 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Local Drug Delivery Based Treatment Approaches for Effective Management of Periodontitis
Current Drug Therapy Sustained Delivery of Interferons by Micro- and Nanosystems
Recent Patents on Materials Science Synthesis of Dihydropyridines: Patented Catalysts and Biological Applications
Recent Patents on Catalysis (Discontinued) Applications of Mesoporous Materials as Excipients for Innovative Drug Delivery and Formulation
Current Pharmaceutical Design The Role of the Osteoimmune Axis in the Inflammation of the Inner Auditory Ear and with Regard to the Putative Anticarcinogenetic Principle: Part 2
Inflammation & Allergy - Drug Targets (Discontinued) Peptides in Oral Diseases
Current Pharmaceutical Design Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Potential Use of Polymeric Nanoparticles for Drug Delivery Across the Blood-Brain Barrier
Current Medicinal Chemistry Antimicrobial Activity of Biosynthesized Metal Nanoparticles
Current Nanomedicine Clinical Correlations of Lipid Profiles with the Age and Gender in the Coronary Artery Disease Patients: A Study of 3878 CAD Patients from India
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular, Cellular and Pharmaceutical Aspects of Autologous Grafts for Peri-implant Hard and Soft Tissue Defects
Current Pharmaceutical Biotechnology Antibacterial and Anti-inflammatory Activities of Ppc-1, Active Principle of the Cellular Slime Mold Polysphondylium pseudo-candidum
Medicinal Chemistry The Role of Co-Infections in Mother-to-Child Transmission of HIV
Current HIV Research Editorial (Thematic Issue: Micro and Nanoscale Materials for Boosting the Antimicrobial Fight)
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: The Crosstalk between Non-Pharmaceutical and Pharmaceutical Approaches to Prevention and Treatment of Chronic Diseases: Current Concepts and Perspectives)
Current Pharmaceutical Design Anti-Biofilm Strategies and the Need for Innovations in Wound Care
Recent Patents on Anti-Infective Drug Discovery Three-dimensional Pattern of Inflammatory Periapical Lesion Extension in the Premolar’s Region: An Application of K-means Clustering
Current Medical Imaging Alveolar Bone Mineral Density Measurement using CBCT Images
Neuroscience and Biomedical Engineering (Discontinued) Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol
CNS & Neurological Disorders - Drug Targets